Catalyst Wire Dossier Catalyst Wire Dossier

TR-701 Free Acid (FA)

TR-701 · Trius Therapeutics LLC (a subsidiary of Merck & Co., Inc.)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TR-701 Free Acid (FA), covering 2017-10-06 to 2017-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly Subjects [Phase 1]

See pricing